Limitations
The major limitation of our study is the lack of a control group who
were not treated by HCQ. The subgroup analyses may have reached a
significant number if the study population was further. We also don’t
know the exact number of cardiomyopathies related with COVID-19 among
our patients because they did not have echocardiographic evaluation if
not required.